Literature DB >> 10995557

Ocular and extraocular inflammation induced by immunization of tyrosinase related protein 1 and 2 in Lewis rats.

K Yamaki1, I Kondo, H Nakamura, M Miyano, S Konno, S Sakuragi.   

Abstract

Vogt-Koyanagi-Harada (VKH) disease is an ocular inflammatory disease and is considered to be a cell-mediated, autoimmune disease against melanocytes. To learn more about the mechanisms involved in VKH disease, the identification of the antigens specific to the disease and the development of an animal model are critically important. We have expressed and purified the melanocyte specific proteins, tyrosinase-related protein 1 (TRP1) and 2 (TRP2). Lewis rats developed an ocular and extraocular inflammatory disease 12 days after immunization with TRP1 or TRP2 that was characterized clinically by the infiltration of inflammatory cells and accumulation of massive fibrin in the anterior and posterior chambers of the eye. Histologically, inflammatory cells were found in the anterior and posterior chambers, iris, ciliary body, the choroid, subretinal space and vitreous body. In severe cases, a serous detachment of the retina was observed. In mild cases, focal inflammatory lesions surrounded by normal chorioretinal architecture were observed and the inflammation persisted for more than 42 days after the injection. Some eyes showed accumulation of epithelioid cells in the choroid or the retinal pigment epithelium which were similar to the Dalen-Fuchs nodules found in patients with VKH disease. The alterations of the photoreceptor outer segment and the outer nuclear layer were less severe than in experimental autoimmune uveitis induced by retinal antigens. Extraocular manifestations such as skin lesions and meningitis were also observed. The clinical course and histological findings in these rats resembled the changes in patients with VKH disease. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10995557     DOI: 10.1006/exer.2000.0893

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  18 in total

1.  Vogt-Koyanagi-Harada disease occurring during interferon-alpha and ribavirin therapy for chronic hepatitis C virus infection.

Authors:  Abdulrahman M Al-Muammar; Tariq M Al-Mudhaiyan; Mohammed Al Otaibi; Ayman Abdo; Ahmed M Abu El-Asrar
Journal:  Int Ophthalmol       Date:  2010-02-23       Impact factor: 2.031

2.  Recovery of macular cone photoreceptors in Vogt-Koyanagi-Harada disease.

Authors:  Tomoko Nakamura; Atsushi Hayashi; Toshihiko Oiwake
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-12-20       Impact factor: 3.117

3.  Incidence and clinical features of recurrent Vogt-Koyanagi-Harada disease in Japanese individuals.

Authors:  Chiharu Iwahashi; Kensuke Okuno; Noriyasu Hashida; Kei Nakai; Nobuyuki Ohguro; Kohji Nishida
Journal:  Jpn J Ophthalmol       Date:  2015-03-26       Impact factor: 2.447

4.  Outcomes of initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease occurred during pregnancy.

Authors:  Arwa Z Alromaih; Abdullah I Almater; Abdulrahman F Albloushi; Norah F Alkheraiji; Ahmed M Abu El-Asrar
Journal:  Int Ophthalmol       Date:  2022-08-09       Impact factor: 2.029

5.  Initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease presenting with unilateral exudative retinal detachment despite bilateral choroidal involvement.

Authors:  Abdulrahman F AlBloushi; Carl P Herbort; Ahmed M Abu El-Asrar
Journal:  Int Ophthalmol       Date:  2021-08-03       Impact factor: 2.031

6.  Prognostic factors in Vogt-Koyanagi-Harada disease.

Authors:  Abdullah S Al-Kharashi; Hassan Aldibhi; Hamad Al-Fraykh; Dustan Kangave; Ahmed M Abu El-Asrar
Journal:  Int Ophthalmol       Date:  2007-04-14       Impact factor: 2.029

7.  High incidence of antibodies to lens proteins in sera from patients with uveitis.

Authors:  Deshka Doycheva; Doycheva Deshka; Beate Preuss; Preuss Beate; Reinhild Klein; Klein Reinhild; Manfred Zierhut; Zierhut Manfred
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-09-19       Impact factor: 3.535

8.  Label-free proteomics reveals decreased expression of CD18 and AKNA in peripheral CD4+ T cells from patients with Vogt-Koyanagi-Harada syndrome.

Authors:  Liming Mao; Peizeng Yang; Shengping Hou; Fuzhen Li; Aize Kijlstra
Journal:  PLoS One       Date:  2011-01-28       Impact factor: 3.240

Review 9.  Precise, simplified diagnostic criteria and optimised management of initial-onset Vogt-Koyanagi-Harada disease: an updated review.

Authors:  Carl P Herbort; Ilknur Tugal-Tutkun; Ahmed Abu-El-Asrar; Amod Gupta; Masaru Takeuchi; Christine Fardeau; Alireza Hedayatfar; Cristhian Urzua; Ioannis Papasavvas
Journal:  Eye (Lond)       Date:  2021-06-18       Impact factor: 3.775

10.  Influence of early cerebrospinal fluid-guided diagnosis and early high-dose corticosteroid therapy on ocular outcomes of Vogt-Koyanagi-Harada disease.

Authors:  Masaru Miyanaga; Tatushi Kawaguchi; Kentaro Shimizu; Kazunori Miyata; Manabu Mochizuki
Journal:  Int Ophthalmol       Date:  2007-05-03       Impact factor: 2.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.